Per Broberg

4.3k total citations
32 papers, 732 citations indexed

About

Per Broberg is a scholar working on Genetics, Physiology and Epidemiology. According to data from OpenAlex, Per Broberg has authored 32 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 9 papers in Physiology and 8 papers in Epidemiology. Recurrent topics in Per Broberg's work include Inflammatory Bowel Disease (6 papers), Microscopic Colitis (5 papers) and Asthma and respiratory diseases (5 papers). Per Broberg is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Microscopic Colitis (5 papers) and Asthma and respiratory diseases (5 papers). Per Broberg collaborates with scholars based in Sweden, United Kingdom and Netherlands. Per Broberg's co-authors include Håkan Olsson, Amelie Plymoth, Signe Borgquist, Bo Nordén, Stefan Pierrou, Stephen T. Holgate, Eva Lindqvist, Sebastian Möller, Johan Lund and Elisabet Wieslander and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Per Broberg

32 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Per Broberg Sweden 15 260 195 124 123 103 32 732
Jennifer A. Kennedy Australia 14 351 1.4× 111 0.6× 63 0.5× 90 0.7× 93 0.9× 33 897
Ryan Deaton United States 17 260 1.0× 176 0.9× 47 0.4× 61 0.5× 56 0.5× 39 737
Adelheid Kratzer United States 17 302 1.2× 129 0.7× 47 0.4× 100 0.8× 70 0.7× 26 753
Ning Zhu China 19 340 1.3× 171 0.9× 39 0.3× 72 0.6× 107 1.0× 61 817
Takeshi Ozeki Japan 15 196 0.8× 88 0.5× 113 0.9× 79 0.6× 42 0.4× 54 1.1k
Fiorella Guadagni Italy 18 320 1.2× 140 0.7× 67 0.5× 116 0.9× 48 0.5× 43 989
Muhammad Arif Sweden 22 516 2.0× 66 0.3× 94 0.8× 166 1.3× 136 1.3× 65 1.0k
Michael Tapner Australia 13 140 0.5× 141 0.7× 41 0.3× 69 0.6× 81 0.8× 27 965
Qun Liu China 15 234 0.9× 163 0.8× 67 0.5× 30 0.2× 60 0.6× 41 687
Toshihiko Nagasawa Japan 23 439 1.7× 345 1.8× 67 0.5× 117 1.0× 88 0.9× 98 1.4k

Countries citing papers authored by Per Broberg

Since Specialization
Citations

This map shows the geographic impact of Per Broberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Broberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Broberg more than expected).

Fields of papers citing papers by Per Broberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Broberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Broberg. The network helps show where Per Broberg may publish in the future.

Co-authorship network of co-authors of Per Broberg

This figure shows the co-authorship network connecting the top 25 collaborators of Per Broberg. A scholar is included among the top collaborators of Per Broberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Broberg. Per Broberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strosberg, Jonathan, Rajaventhan Srirajaskanthan, Ghassan El‐Haddad, et al.. (2021). Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE. Journal of Nuclear Medicine. 62(12). 1712–1718. 14 indexed citations
2.
Johnsson, Anna, Per Broberg, Ute Krüger, et al.. (2019). Physical activity and survival following breast cancer. European Journal of Cancer Care. 28(4). e13037–e13037. 19 indexed citations
3.
Borgquist, Signe, et al.. (2019). Statin use and breast cancer survival – a Swedish nationwide study. BMC Cancer. 19(1). 54–54. 54 indexed citations
4.
Olsson, Håkan, et al.. (2019). Participation in a Prospective Cohort Study on Melanoma did not Affect the Incidence and Mortality of the Studied Disease. Acta Dermato Venereologica. 100(1). 1–6. 3 indexed citations
5.
Olsson, Håkan, et al.. (2018). Effects of antihistamine use on survival in breast cancer.. Journal of Clinical Oncology. 36(15_suppl). e12527–e12527. 2 indexed citations
6.
Regnell, Simon E., Pernilla Peterson, Per Broberg, et al.. (2015). Magnetic resonance imaging reveals altered distribution of hepatic fat in children with type 1 diabetes compared to controls. Metabolism. 64(8). 872–878. 30 indexed citations
7.
Broberg, Per. (2013). Sample size re-assessment leading to a raised sample size does not inflate type I error rate under mild conditions. BMC Medical Research Methodology. 13(1). 94–94. 8 indexed citations
8.
Bokemeyer, Bernd, et al.. (2011). Mesalazine in left-sided ulcerative colitis: Efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing. Journal of Crohn s and Colitis. 6(4). 476–482. 34 indexed citations
9.
Pettersson, Göran, Anders Nyboe Andersen, Per Broberg, & Joan‐Carles Arce. (2010). Pre-stimulation parameters predicting live birth after IVF in the long GnRH agonist protocol. Reproductive BioMedicine Online. 20(5). 572–581. 9 indexed citations
10.
Marteau, Philippe, Marco Oudkerk Pool, Per Karlén, et al.. (2010). T1252 Early Response to Combined Oral and Topical Mesalazine (Pentasa®) for Ulcerative Colitis: Post-Hoc Analysis of Efficacy at Two Weeks in the PINCE Trial. Gastroenterology. 138(5). S–521. 2 indexed citations
11.
Plymoth, Amelie, Claes-Göran Löfdahl, Ann Ekberg‐Jansson, et al.. (2007). Protein Expression Patterns Associated with Progression of Chronic Obstructive Pulmonary Disease in Bronchoalveolar Lavage of Smokers. Clinical Chemistry. 53(4). 636–644. 36 indexed citations
12.
Shaker, Saher Burhan, Karin von Wachenfeldt, Susanne Larsson, et al.. (2007). Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers. The Clinical Respiratory Journal. 2(1). 17–25. 25 indexed citations
13.
Pierrou, Stefan, Per Broberg, Rory O’Donnell, et al.. (2006). Expression of Genes Involved in Oxidative Stress Responses in Airway Epithelial Cells of Smokers with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 175(6). 577–586. 169 indexed citations
14.
Nordén, Bo, et al.. (2005). Analysis and Understanding of High-Dimensionality Data by Means of Multivariate Data Analysis. Chemistry & Biodiversity. 2(11). 1487–1494. 42 indexed citations
15.
Broberg, Per. (2005). A comparative review of estimates of the proportion unchanged genes and the false discovery rate. BMC Bioinformatics. 6(1). 199–199. 65 indexed citations
16.
Broberg, Per. (2003). Statistical methods for ranking differentially expressed genes. Genome biology. 4(6). R41–R41. 81 indexed citations
17.
Larsson, Susanne, Lennart Hansson, Lennart Greiff, et al.. (2002). Natural allergen exposure does not diminish the sensitivity of cytokine production to glucocorticosteroids in blood cells of seasonal allergic asthma and rhinitis patients. Respiratory Medicine. 96(11). 927–933. 2 indexed citations
18.
Broberg, Per. (2002). Ranking genes with respect to differential expression.. Genome Biology. 3(9). preprint0007.1–preprint0007.1. 19 indexed citations
19.
Broberg, Per. (1999). Estimation of Relative SD. Drug Development and Industrial Pharmacy. 25(1). 37–43. 1 indexed citations
20.
Broberg, Per. (1988). Critical branching populations with reproductive sibling correlations. Stochastic Processes and their Applications. 30(1). 133–147. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer A. Kennedy Breakdown of academic impact, for papers by Ryan Deaton Breakdown of academic impact, for papers by Adelheid Kratzer Breakdown of academic impact, for papers by Ning Zhu Breakdown of academic impact, for papers by Takeshi Ozeki Breakdown of academic impact, for papers by Fiorella Guadagni Breakdown of academic impact, for papers by Muhammad Arif Breakdown of academic impact, for papers by Michael Tapner Breakdown of academic impact, for papers by Qun Liu Breakdown of academic impact, for papers by Toshihiko Nagasawa
Rankless by CCL
2026